The FDA has granted Regenerative Medicine Advanced Therapy designation to NouvNeu001, a cell therapy for Parkinson’s disease. NouvNeu001, developed by iRegene, is the first allogeneic cell therapy ...

About 1 million Americans suffer from Parkinson's disease, with around 90,000 new cases diagnosed each year, according to the ...

Chinese researchers have developed a new stem cell therapy for Parkinson’s disease which reportedly provides rapid ...

The RMAT designation is intended to expedite the development and evaluation of regenerative medicine therapies.

Researchers have identified a key molecular interaction that accelerates Parkinson’s disease by damaging the brain’s energy ...

Northwestern Medicine scientists have discovered that targeting neuronal signaling controlling aberrant learning in the striatum may improve the efficacy of a first-line therapy for Parkinson's ...

Scientists have identified the role of an ion channel that plays a key part in how cells break down and recycle components, a ...

Bial has introduced a new sublingual formulation of apomorphine in the UK, offering a fresh treatment option for adults with Parkinson’s disease who experience intermittent OFF episodes that are not ...

Korean researchers say this common bacterium's journey throughout the body could lead to consequences in the brain.

Some Parkinson’s patients may experience strange symptoms, like smell loss and sleep disorders, decades before diagnosis.

In people with Parkinson's disease, dysphagia is usually treated first with medicines that aim to improve the symptoms of Parkinson’s disease overall. If swallowing problems continue, rehabilitation ...

Scientists report that specific RNA patterns in blood may detect Parkinson’s disease early, opening a window for earlier care ...